Brain, Brain Imaging, Neuroscience, Prefrontal Cortex
NIMH Postdoctoral Fellowship, Mount Sinai School of Medicine
MPH, Harvard University
PhD, University of Oxford, Magdalen College
Translational Molecular Imaging Institute Annual Symposium
Clifford Yorke Prize
International Neuropsychoanalysis Society
Symposium Fellow and Travel Award
Health Emotions Research Institute
Phillip M. Rennick Award
International Neuropsychological Society
CDI Travel Award
American College of Psychopharmacology Annual Meeting
New York Academy of Sciences Fellowship
Young Investigator Award
American Neuropsychiatric Association
Young Investigator Award
National Education Alliance for Borderline Personality Disorder
Harvard University Fellowship
Magdalen College, Oxford
British Council Overseas Research Scholarship
Berlin HA. The neural basis of the dynamic unconscious. Neuropsychoanalysis 2011; 13(1): 5-31.
Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. A double-blind, placebo-controlled trial of topiramate for pathological gambling. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011 Apr;.
Goldstein KE, Hazlett EA, Savage KR, Berlin HA, Hamilton HK, Zelmanova Y, Look AE, Koenigsberg HW, Mitsis EM, Tang CY, McNamara M, Siever LJ, Cohen BH, New AS. Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder. Behavioural brain research 2011 Apr; 218(2).
Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. The Journal of clinical psychiatry 2011 May; 72(5).
Altamura AC, Dell'Osso B, Berlin HA, Buoli M, Bassetti R, Mundo E. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. European archives of psychiatry and clinical neuroscience 2010 Aug; 260(5).
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010 Feb; 35(3).
Dell'Osso B, Berlin HA, Serati M, Altamura AC. Neuropsychobiological aspects, comorbidity patterns and dimensional models in borderline personality disorder. Neuropsychobiology 2010; 61(4).
Dell'Osso B, Camuri G, Berlin HA, Serati M, Altamura AC. A dimensional approach to borderline personality disorder. Italian J of Psychopathology 2009; 15: 48-63.
Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology 2008; 58(1).
Berlin HA, Hamilton H, Hollander E. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. The Mount Sinai journal of medicine, New York; 75(3).
Berlin HA. Antiepileptic drugs for the treatment of impulsivity. Current Psychiatry Reviews 2008; 4(3): 114-136.
Berlin HA. Antiepileptic drugs for the treatment of post-traumatic stress disorder. Current psychiatry reports 2007 Aug; 9(4).
Berlin HA, Rolls ET, Iversen SD. Borderline personality disorder, impulsivity, and the orbitofrontal cortex. The American journal of psychiatry 2005 Dec; 162(12).
Berlin HA, Rolls ET, Kischka U. Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain : a journal of neurology 2004 May; 127(Pt 5).
Berlin HA, Rolls ET. Time perception, impulsivity, emotionality, and personality in self-harming borderline personality disorder patients. Journal of personality disorders 2004 Aug; 18(4).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Berlin did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.